Summary
Updated Aug 30, 2026
William Ordemann is Director of Kinetik Holdings Inc. (KNTK). 2 SEC Form 4 filings on record going back to 2025, most recently on 20 May 2026.
Recent Transactions
3Every recent SEC Form 4 transaction William Ordemann has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies William Ordemann files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ISQ Global Fund II GP LLC - $289.19M of KNTK open-market activity in the last 12 months
- Laura A. Sugg - $3.20M of KNTK open-market activity in the last 12 months
- Jamie Welch - $472K of KNTK open-market activity in the last 12 months
- Matthew Wall - $151K of KNTK open-market activity in the last 12 months
- Deborah L. Byers - $141K of KNTK open-market activity in the last 12 months
- Steven Stellato - $136K of KNTK open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is William Ordemann?
William Ordemann is a corporate insider, tracked as Director of Kinetik Holdings Inc. (KNTK). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did William Ordemann last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 2 filings going back to 2025.
Where can I see all of William Ordemann's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow William Ordemann and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial